Acadia Healthcare (ACHC) Tops Q2 EPS by 4c; offers guidance

Acadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.91, $0.04 better than the analyst estimate of $0.87. Revenue for the quarter came in at $796 million versus the consensus estimate of $784.38 million.

GUIDANCE:

Acadia Healthcare sees FY2024 EPS of $3.45-$3.65, versus the consensus of $3.49. Acadia Healthcare sees FY2024 revenue of $3.18-3.225 billion, versus the consensus of $3.2 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Acadia Healthcare (ACHC) Reiterated at Neutral by Cantor Fitzgerald on Negative June Data
• Biogen expects $164M R&D charge to hit Q2 2026 earnings
• Coty reorganizes leadership, sees three executives depart